Judge refuses to dismiss states' Suboxone suit

Indivior has failed to convince a federal judge to dismiss a lawsuit alleging that the drugmaker engaged in product-hopping to keep low-cost generic drugs from competing with its opioid-addiction treatment Suboxone.

Get unlimited access to all Global Competition Review content